[Current therapy of multiple sclerosis. Oral tolerance induction to myelin antigens].
Voltz
R
R
Neurologische Klinik, Ludwig-Maximilians-Universität, Klinikum Grosshadern, München.
Hohlfeld
R
R
D015478:Antigens, Heterophile / Q000008:administration & dosage* / Q000276:immunology; D001324:Autoantigens / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*; D009185:Myelin Proteins / Q000008:administration & dosage / Q000276:immunology*; D009460:Neurologic Examination
D015478:Antigens, Heterophile; D001324:Autoantigens; D009185:Myelin Proteins
Aktuelle Therapie der multiplen Sklerose. Orale Toleranzinduktion gegen Myelinantigene.